Specifically, the company states that FDA-approved GLP-1/GIP medications for weight loss and type 2 diabetes, including Ozempic, Wegovy, Zepbound, and Mounjaro, "may also be eligible for coverage." The company further states that while they "assist with prior authorizations and prescription submissions," they "do not bill insurance directly." This distinction is important: the compounded GLP-1 program itself is described as a cash-pay arrangement, but the company also facilitates access to FDA-approved branded medications that may have insurance pathways
For gut issues, oral dosing targets the GI tract
A study showed the potential of EGCG in PD treatment by analyzing its impact on the peripheral immune system
Many patients wonder whether these two medications can be safely taken together, and the answer is nuancedit requires close communication with your healthcare provider and regular monitoring
Nanomedicines reprogram synovial macrophages by scavenging nitric oxide and silencing ca9 in progressive osteoarthritis
Efficacy and toxicological evaluation of Coccinia grandis (Cucurbitaceae) extract in male wistar rats
